Bradycardia / sinus bradycardia
- (2021): Cirne F+, Lung Cancer Aug, Online ahead of print [REVIEW]
Adverse reactions attributed to entire drug class 'Anaplastic lymphoma kinase (ALK) inhibitor'
Please login to view adverse reactions.
- (2022): Sisi M+, Target Oncol 17(1), 43-51 (95 cases) (pharmacovigilance / pharmacoepidemiology)
Hepatotoxicity / liver injury / acute liver injury / drug-induced liver injury (DILI)
- (2021): Zhou Z+, J Clin Pharm Ther Mar, Online ahead of print [REVIEW]
- (2025): Frey C, Can J Physiol Pharmacol Apr, Online ahead of print [REVIEW] (pharmacovigilance / pharmacoepidemiology)
- (2020): Koshikawa K+, Thorac Cancer Apr, Epub ahead of print (7 cases)
Adverse effects / adverse reactions
- (2023): Liao D+, Int Immunopharmacol Feb, Online ahead of print (with immune checkpoint inhibitor)
- (2019): Hou H+, Cancer Manag Res 11, 4109>95% (20% serious) [REVIEW]
- (2018): Costa RB+, Oncotarget 9(31), 22137-22146 [REVIEW]
